A chip-based infection model developed by researchers in Jena, Germany, enables live microscopic observation of damage to lung tissue caused by the invasive fungal infection aspergillosis. The team developed algorithms to track the spread of fungal hyphae as well as the response of immune cells. The development is based on a “lung-on-chip” model also developed in Jena and can help reduce the number of animal experiments. The results were presented in the journal Biomaterials.
Aspergillosis is a mold infection caused by Aspergillus fumigatus, which often affects the lungs. The disease can be fatal, especially in immunocompromised individuals. In these cases, invasive aspergillosis usually occurs with fungal hyphae invading blood vessels. So far, there are only a few active substances that can combat such fungal infections. “That’s why it was so important for us to be able to represent this invasive growth in a model,” says Marie von Lilienfeld-Toal, who co-led the study. The internist is a professor at the Department of Internal Medicine II at Jena University Hospital and conducts research at the Leibniz Institute for Natural Product Research and Infection Biology—Hans Knöll Institute (Leibniz-HKI) in Jena, Germany.
The new aspergillosis infection model should help to better observe both the growth of the fungus and the reaction of the immune system and to find possible new approaches for therapies. In addition, new active substances can be tested. The expertise for this is available in Jena: Organ chips have long been developed at the university hospital. The startup Dynamic42, which manufactures the lung chips used in the study, was founded there. First author Mai Hoang also joined the company after completing her doctorate.